Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Liraglutide structure

Liraglutide

Metabolic
Approved Research
100%
Low Risk
1/5

Warnings

Black box warning for thyroid C-cell tumors
Risk of pancreatitis
Gallbladder disease risk

Contraindications

PregnancyBreastfeedingPersonal Or Family History MTCMEN2 SyndromePancreatitis History

Drug Interactions

InsulinSulfonylureas

Possible Side Effects

NauseaDiarrheaVomitingConstipationHeadacheHypoglycemia

Legal & Regulatory

FDA Status FDA Approved
WADA Status Not Prohibited
Approved In USA, EU, Canada, Australia, Japan
Prescription Required

Pregnancy

Category X - Contraindicated